Back to Search
Start Over
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)
- Source :
- Pediatric Rheumatology Online Journal, Vol 6, Iss Suppl 1, p S2 (2008)
- Publication Year :
- 2008
- Publisher :
- BMC, 2008.
- Subjects :
- Pediatrics
RJ1-570
Diseases of the musculoskeletal system
RC925-935
Subjects
Details
- Language :
- English
- ISSN :
- 15460096
- Volume :
- 6
- Issue :
- Suppl 1
- Database :
- Directory of Open Access Journals
- Journal :
- Pediatric Rheumatology Online Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2c0fcb64a744e60981ea3944e416a11
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/1546-0096-6-S1-S2